Pharmaceutical development and specification of stereoisomers Pharmaceutical and biomedical analysis 1983-1997: The end of an era

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical and biomedical analysis Vol. 17; no. 6-7; pp. 917 - 924
Main Authors WILLIAMS, R. C, RILEY, C. M, SIGVARDSON, K. W, FORTUNAK, J, MA, P, NICOLAS, E. C, UNGER, S. E, KRAHN, D. F, BREMNER, S. L
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Science 1998
Subjects
Biological and medical sciences
General pharmacology
Medical sciences
Pharmacology. Drug treatments
Physicochemical properties. Structure-activity relationships
Drug
Stereoisomer
Enantiomer
Chiral compound
Research and development
Recommendation
Online AccessGet full text

Cover

Author RILEY, C. M
MA, P
NICOLAS, E. C
UNGER, S. E
FORTUNAK, J
BREMNER, S. L
SIGVARDSON, K. W
KRAHN, D. F
WILLIAMS, R. C
Author_xml – sequence: 1
  givenname: R. C
  surname: WILLIAMS
  fullname: WILLIAMS, R. C
  organization: Pharmaceutical Research and Development, DuPont Merck Pharmaceutical Company, Experimental Station, PO Box 80353, Wilmington, DE 19880, United States
– sequence: 2
  givenname: C. M
  surname: RILEY
  fullname: RILEY, C. M
  organization: Pharmaceutical Research and Development, DuPont Merck Pharmaceutical Company, Experimental Station, PO Box 80353, Wilmington, DE 19880, United States
– sequence: 3
  givenname: K. W
  surname: SIGVARDSON
  fullname: SIGVARDSON, K. W
  organization: Pharmaceutical Research and Development, DuPont Merck Pharmaceutical Company, Experimental Station, PO Box 80353, Wilmington, DE 19880, United States
– sequence: 4
  givenname: J
  surname: FORTUNAK
  fullname: FORTUNAK, J
  organization: Chemical Process Research and Development, DuPont Merck Pharmaceutical Company, Experimental Station. PO Box 80353, Wilmington, DE 19880, United States
– sequence: 5
  givenname: P
  surname: MA
  fullname: MA, P
  organization: Chemical Process Research and Development, DuPont Merck Pharmaceutical Company, Experimental Station. PO Box 80353, Wilmington, DE 19880, United States
– sequence: 6
  givenname: E. C
  surname: NICOLAS
  fullname: NICOLAS, E. C
  organization: Analytical R&D, Sanofi Winthrop, Malvern, PA 19355, United States
– sequence: 7
  givenname: S. E
  surname: UNGER
  fullname: UNGER, S. E
  organization: Drug Metabolism and Pharmacokinetics, DuPont Merck Pharmaceutical Company, Experimental Station, PO Box 80353, Wilmington, DE 19880, United States
– sequence: 8
  givenname: D. F
  surname: KRAHN
  fullname: KRAHN, D. F
  organization: Safety Assessment, DuPont Merck Pharmaceutical Company, Experimental Station, PO Box 80353, Wilmington, DE 19880, United States
– sequence: 9
  givenname: S. L
  surname: BREMNER
  fullname: BREMNER, S. L
  organization: Chemical and Physical Sciences, DuPont Merck Pharmaceutical Company, Experimental Station, PO Box 80353, Wilmington, DE 19880, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1662873$$DView record in Pascal Francis
BookMark eNqNjr0KwjAURoNUsFXfIYNrIf2vg5Mojg4ObuWS3mCk-SE3Cr69HXwAp284h8OXscQ6iwuWFn1X5WVb3xOWiq4q8k70zYplRE8hRFPs65Qdrg8IBiS-opYw8RHfODlv0EYOduTkUWo1o6id5U5xihjQaXIGA23YUsFEuP3tmu3Op9vxknuguaYCWKlp8EEbCJ-haNty_lT9qX0B5uw9yg
CODEN JPBADA
ContentType Journal Article
Copyright 1999 INIST-CNRS
Copyright_xml – notice: 1999 INIST-CNRS
DBID IQODW
DatabaseName Pascal-Francis
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-264X
EndPage 924
ExternalDocumentID 1662873
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
29L
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
9JM
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARLI
AATCM
AAXUO
ABFNM
ABFRF
ABJNI
ABMAC
ABMYL
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACNNM
ACRLP
ADBBV
ADECG
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJQLL
AJSZI
AKRWK
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FLBIZ
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HMU
HVGLF
HZ~
IHE
IQODW
J1W
KOM
M34
M36
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
RNS
ROL
RPZ
SCB
SCC
SCH
SDF
SDG
SDP
SES
SEW
SPC
SPCBC
SPT
SSK
SSP
SSZ
T5K
TEORI
WUQ
XFK
XPP
YK3
~G-
ID FETCH-pascalfrancis_primary_16628733
ISSN 0731-7085
IngestDate Mon Mar 18 05:06:37 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6-7
Keywords Drug
Stereoisomer
Enantiomer
Chiral compound
Research and development
Recommendation
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-pascalfrancis_primary_16628733
ParticipantIDs pascalfrancis_primary_1662873
PublicationCentury 1900
PublicationDate 1998
PublicationDateYYYYMMDD 1998-01-01
PublicationDate_xml – year: 1998
  text: 1998
PublicationDecade 1990
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
PublicationTitle Journal of pharmaceutical and biomedical analysis
PublicationYear 1998
Publisher Elsevier Science
Publisher_xml – name: Elsevier Science
SSID ssj0005194
Score 3.0997162
SourceID pascalfrancis
SourceType Index Database
StartPage 917
SubjectTerms Biological and medical sciences
General pharmacology
Medical sciences
Pharmacology. Drug treatments
Physicochemical properties. Structure-activity relationships
Subtitle Pharmaceutical and biomedical analysis 1983-1997: The end of an era
Title Pharmaceutical development and specification of stereoisomers
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8JAEN4YTl6Mz_jC7IFwkTbQLdv2SIyKEpFoSbiRbncbPUgJ4AEP_nZnH_RBiK9L026TTdtvOp2dft8MQjUeOxwiXWY5Dm9aLnE9eKVgleInxCGCcpcpofBDn3aH7v2oPcp5ukpdsmB2_LFRV_IfVGEMcJUq2T8gm00KA7AP-MIWEIbtrzAevJQS0jwnAKl_AlJFKZlAWVQoiyKI9HWevhne-4awdFqeU86jJfrmUNcwyXy5SQYopOw85fokS3WrJKxd6Fh8dyt7fTw_KmpBz77M8juwFA2H_U4v_0_FV8q8PC-20sYYd1RwYR5pWV5TN-WxhXaxvkckr25U8sFewdao5RVcamDO6a9zoBXX5cLZax-0jGbYohQWhLIUrKwhBM7O_izwf1qqS2Z2iZIVG83hUSa6o0khzAh30Y4BAnc02HtoS0z2Ud0AvWzgMNfLzRu4jgd56fHlAVqzCFywCAxI4pJF4DTBJYs4RLWb6_Cqa5WucDzVBUnG5j7JEapM0ok4RjjwI-bFPhXNgLkuTyLWZn7MBY39iApCTlD126lOfzh_hra1OFPmos5RZTF7F1WIzhbsQj3lLyfvSBI
link.rule.ids 315,786,790,4043
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmaceutical+development+and+specification+of+stereoisomers&rft.jtitle=Journal+of+pharmaceutical+and+biomedical+analysis&rft.au=WILLIAMS%2C+R.+C&rft.au=RILEY%2C+C.+M&rft.au=SIGVARDSON%2C+K.+W&rft.au=FORTUNAK%2C+J&rft.date=1998&rft.pub=Elsevier+Science&rft.issn=0731-7085&rft.eissn=1873-264X&rft.volume=17&rft.issue=6-7&rft.spage=917&rft.epage=924&rft.externalDBID=n%2Fa&rft.externalDocID=1662873
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0731-7085&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0731-7085&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0731-7085&client=summon